documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
98 rows where docket_id = "FDA-2008-N-0039" sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: subtype, posted_month, comment_start_date, posted_date (date), comment_start_date (date), last_modified (date)
document_type 3
- Rule 54
- Supporting & Related Material 39
- Notice 5
agency_id 1
- FDA 98
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2008-N-0039-0098 | FDA | None FDA-2008-N-0039 | Supplement Abbreviated New Animal Drug Application; Flunazine, (flunixin meglumine), Injectable Solution, Horses and Cattle - Freedom of Information Summary | Supporting & Related Material | Freedom of Information Summary | 2009-02-12T05:00:00Z | 2009 | 2 | 2014-01-08T14:19:17Z | 0 | 0 | 09000064808548d1 | |||
| FDA-2008-N-0039-0097 | FDA | None FDA-2008-N-0039 | Implantation or Injectable Dosage Form New Animal Drugs: Flunixin - Final Rule | Notice | Notice of Final Rule | 2009-02-12T05:00:00Z | 2009 | 2 | 2014-01-08T14:17:02Z | E9-02941 | 0 | 0 | 09000064808545a3 | ||
| FDA-2008-N-0039-0096 | FDA | None FDA-2008-N-0039 | Supplemental Abbreviated New Animal Drug Application - PHOENECTIN Paste 1.87%, (ivermectin), Oral Paste-Horses - Freedom of Information Summary | Supporting & Related Material | Freedom of Information Summary | 2009-02-10T05:00:00Z | 2009 | 2 | 2014-01-08T14:16:01Z | 0 | 0 | 090000648084fa4c | |||
| FDA-2008-N-0039-0095 | FDA | None FDA-2008-N-0039 | Oral Dosage Form New Animal Drugs: Ivermectin Paste - Final Rule | Rule | Final Rule | 2009-02-10T05:00:00Z | 2009 | 2 | 2009-02-10T05:00:00Z | 2014-01-08T14:11:50Z | E9-02749 | 0 | 0 | 090000648084f677 | |
| FDA-2008-N-0039-0094 | FDA | None FDA-2008-N-0039 | Oral Dosage Form New Animal Drugs: Phenylbutazone Tablets and Boluses | Rule | Final Rule | 2009-01-12T05:00:00Z | 2009 | 1 | 2009-01-12T05:00:00Z | 2013-07-09T19:32:23Z | E9-00265 | 0 | 0 | 090000648081b72e | |
| FDA-2008-N-0039-0093 | FDA | None FDA-2008-N-0039 | New Animal Drugs for Use in Animal Feeds; Tiamulin | Rule | Final Rule | 2009-01-02T05:00:00Z | 2009 | 1 | 2009-01-02T05:00:00Z | 2013-07-09T19:38:10Z | E8-31128 | 0 | 0 | 090000648080c33b | |
| FDA-2008-N-0039-0092 | FDA | None FDA-2008-N-0039 | Freedom of Information Summary - Original Abbreviated New Drug Application - ANADA 200-459 | Supporting & Related Material | Freedom of Information Summary | 2008-12-29T05:00:00Z | 2008 | 12 | 2013-07-09T18:51:04Z | 0 | 0 | 0900006480805f78 | |||
| FDA-2008-N-0039-0091 | FDA | None FDA-2008-N-0039 | Ophthalmic and Topical Dosage Form New Animal Drugs; Triamcinolone Cream | Rule | Final Rule | 2008-12-29T05:00:00Z | 2008 | 12 | 2008-12-29T05:00:00Z | 2013-07-09T18:48:19Z | E8-30694 | 0 | 0 | 0900006480805eeb | |
| FDA-2008-N-0039-0090 | FDA | None FDA-2008-N-0039 | Freedom of Information Summary - NADA 013-076 - TYLAN Soluble Tylosin tartrate Soluble powder Swine | Supporting & Related Material | FOIS-Freedom of Information Summary | 2008-12-18T05:00:00Z | 2008 | 12 | 2008-12-20T16:29:53Z | 0 | 0 | 09000064807e0877 | |||
| FDA-2008-N-0039-0089 | FDA | None FDA-2008-N-0039 | Freedom of Information Summary - NADA 012-491 - TYLAN 40 and TYLAN 100 Tylosin phosphate | Supporting & Related Material | Freedom of Information Summary | 2008-12-18T05:00:00Z | 2008 | 12 | 2013-07-11T14:46:49Z | 0 | 0 | 09000064807e084d | |||
| FDA-2008-N-0039-0088 | FDA | None FDA-2008-N-0039 | New Animal Drugs; Tylosin | Notice | Notice of Final Rule | 2008-12-18T05:00:00Z | 2008 | 12 | 2013-07-11T14:42:33Z | E8-29861 | 0 | 0 | 09000064807e0691 | ||
| FDA-2008-N-0039-0086 | FDA | None FDA-2008-N-0039 | New Animal Drugs for Use in Animal Feeds; Ractopamine | Notice | Notice of Final Rule | 2008-12-11T05:00:00Z | 2008 | 12 | 2013-07-09T20:00:14Z | E8-29177 | 0 | 0 | 09000064807d7057 | ||
| FDA-2008-N-0039-0087 | FDA | None FDA-2008-N-0039 | Freedom of Information (FOI) Summary - Optaflexx (ractopamine hydrochloride), Rumensin (monensin sodium) Tylan (tylosin phosphate) and HEIFERMAX 500 (melengestrol acetate) | Supporting & Related Material | Freedom of Information Summary | 2008-12-11T05:00:00Z | 2008 | 12 | 2013-07-09T20:02:52Z | 0 | 0 | 09000064807d7224 | |||
| FDA-2008-N-0039-0083 | FDA | None FDA-2008-N-0039 | Freedom of Information Summary - Original New Animal Drug Application - NADA 141-290 - TOPMAX 9 (Ractopamine Hydrochloride) Type A Medicated Article Finishing Turkeys | Supporting & Related Material | Freedom of Information Summary | 2008-12-01T05:00:00Z | 2008 | 12 | 2013-07-10T16:18:47Z | 0 | 0 | 09000064807c743a | |||
| FDA-2008-N-0039-0084 | FDA | None FDA-2008-N-0039 | Environmental Assessment For the Use of Topmax® in the Feed of Turkeys | Supporting & Related Material | Environmental Assessment | 2008-12-01T05:00:00Z | 2008 | 12 | 2013-07-10T16:22:43Z | 0 | 0 | 09000064807c7469 | |||
| FDA-2008-N-0039-0082 | FDA | None FDA-2008-N-0039 | New Animal Drugs; Ractopamine | Rule | Final Rule | 2008-12-01T05:00:00Z | 2008 | 12 | 2008-12-01T05:00:00Z | 2013-07-10T16:15:59Z | E8-28384 | 0 | 0 | 09000064807c7111 | |
| FDA-2008-N-0039-0085 | FDA | None FDA-2008-N-0039 | Finding of No Significant Impact - Topmax® (Ractopamine HCl) in the Feed of Turkeys | Supporting & Related Material | Finding of no Significant Impact | 2008-12-01T05:00:00Z | 2008 | 12 | 2013-07-10T16:25:00Z | 0 | 0 | 09000064807c7491 | |||
| FDA-2008-N-0039-0081 | FDA | None FDA-2008-N-0039 | Oral Dosage Form New Animal Drugs; Amprolium; Correction | Rule | Correction | 2008-11-20T05:00:00Z | 2008 | 11 | 2008-11-20T05:00:00Z | 2013-07-11T14:19:15Z | E8-27646 | 0 | 0 | 09000064807b36b5 | |
| FDA-2008-N-0039-0079 | FDA | None FDA-2008-N-0039 | Approval of Original Abbreviated New Animal Drug Application; Phenylbutazone Tablets | Notice | Notice of Approval | 2008-11-12T05:00:00Z | 2008 | 11 | 2013-07-09T19:53:18Z | E8-26793 | 0 | 0 | 09000064807a4da6 | ||
| FDA-2008-N-0039-0080 | FDA | None FDA-2008-N-0039 | Freedom of Information (FOI) Summary - FOIS | Supporting & Related Material | Freedom of Information Summary | 2008-11-12T05:00:00Z | 2008 | 11 | 2013-07-09T19:57:19Z | 0 | 0 | 09000064807a4f83 | |||
| FDA-2008-N-0039-0078 | FDA | None FDA-2008-N-0039 | Freedom of Information Summary - FOIS | Supporting & Related Material | Freedom of Information Summary | 2008-10-31T04:00:00Z | 2008 | 10 | 2013-07-10T18:59:33Z | 0 | 0 | 090000648078785b | |||
| FDA-2008-N-0039-0077 | FDA | None FDA-2008-N-0039 | Oral Dosage Form New Animal Drugs; Firocoxib Tablets | Rule | Final Rule | 2008-10-31T04:00:00Z | 2008 | 10 | 2013-07-10T18:54:17Z | E8-26020 | 0 | 0 | 090000648078769c | ||
| FDA-2008-N-0039-0071 | FDA | None FDA-2008-N-0039 | Implantation or Injectable Dosage Form New Animal Drugs; Tulathromycin | Rule | Final Rule | 2008-10-08T04:00:00Z | 2008 | 10 | 2008-10-08T04:00:00Z | 2013-07-10T18:24:50Z | E8-23832 | 0 | 0 | 090000648073e0bc | |
| FDA-2008-N-0039-0075 | FDA | None FDA-2008-N-0039 | Implantation or Injectable Dosage Form New Animal Drugs; Ceftiofur Crystalline Free Acid | Rule | Final Rule | 2008-10-08T04:00:00Z | 2008 | 10 | 2008-10-08T04:00:00Z | 2013-07-10T19:01:42Z | E8-23830 | 0 | 0 | 090000648073e103 | |
| FDA-2008-N-0039-0074 | FDA | None FDA-2008-N-0039 | Safe-Guard (Fenbendazole) - Freedom of Information Summary | Supporting & Related Material | Freedom of Information Summary | 2008-10-08T04:00:00Z | 2008 | 10 | 2013-07-10T20:13:33Z | 0 | 0 | 090000648073e4e2 | |||
| FDA-2008-N-0039-0076 | FDA | None FDA-2008-N-0039 | Excede (Ceftiofur Crystalline Free Acid) Sterile Suspension - Freedom of Information Summary | Supporting & Related Material | FOIS-Freedom of Information Summary | 2008-10-08T04:00:00Z | 2008 | 10 | 2013-07-10T19:04:11Z | 0 | 0 | 090000648073e577 | |||
| FDA-2008-N-0039-0072 | FDA | None FDA-2008-N-0039 | Draxxin (Tulathromycin) Injectable Solution - Freedom of Information Summary | Supporting & Related Material | Freedom of Information Summary | 2008-10-08T04:00:00Z | 2008 | 10 | 2013-07-10T18:28:38Z | 0 | 0 | 090000648073e476 | |||
| FDA-2008-N-0039-0073 | FDA | None FDA-2008-N-0039 | New Animal Drugs for Use in Animal Feeds; Fenbendazole | Rule | Final Rule | 2008-10-08T04:00:00Z | 2008 | 10 | 2008-10-08T04:00:00Z | 2013-07-10T20:10:36Z | E8-23845 | 0 | 0 | 090000648073e0ff | |
| FDA-2008-N-0039-0070 | FDA | None FDA-2008-N-0039 | Oral Dosage Form New Animal Drugs; Sulfadiazine/Pyrimethamine Suspension | Rule | Final Rule | 2008-09-17T04:00:00Z | 2008 | 9 | 2008-09-17T04:00:00Z | 2013-07-10T18:41:20Z | E8-21625 | 0 | 0 | 090000648070a75b | |
| FDA-2008-N-0039-0068 | FDA | None FDA-2008-N-0039 | Chloramine-T for Control of Bacterial Gill Disease in Freshwater- Reared Salmonids; Availability of Data | Notice | Notice of Availability | 2008-08-21T04:00:00Z | 2008 | 8 | 2013-07-11T14:27:19Z | E8-19299 | 0 | 0 | 09000064806d1357 | ||
| FDA-2008-N-0039-0069 | FDA | None FDA-2008-N-0039 | Freedom of Information Summary Chloramine - T Soluble Powder for Immersion Freshwater - reared salmonids - FOIS | Supporting & Related Material | Freedom of Information Summary | 2008-08-21T04:00:00Z | 2008 | 8 | 2013-07-11T14:29:57Z | 0 | 0 | 09000064806d152a | |||
| FDA-2008-N-0039-0065 | FDA | None FDA-2008-N-0039 | Freedom of Information Summary [New Animal Drugs For Use in Animal Feeds; Oxytetracycline - NADA 38-439] - FOIS | Supporting & Related Material | Freedom of Information Summary | 2008-08-07T04:00:00Z | 2008 | 8 | 2013-07-11T13:49:07Z | 0 | 0 | 09000064806b4494 | |||
| FDA-2008-N-0039-0064 | FDA | None FDA-2008-N-0039 | New Animal Drugs For Use in Animal Feeds; Oxytetracycline | Rule | Final Rule | 2008-08-07T04:00:00Z | 2008 | 8 | 2013-07-11T13:44:20Z | E8-18129 | 0 | 0 | 09000064806b4074 | ||
| FDA-2008-N-0039-0067 | FDA | None FDA-2008-N-0039 | See FDA-2008-N-0039-0066.1 | Supporting & Related Material | Environmental Assessment | 2008-08-07T04:00:00Z | 2008 | 8 | 2013-07-11T13:56:58Z | 0 | 0 | 09000064806b46f9 | |||
| FDA-2008-N-0039-0066 | FDA | None FDA-2008-N-0039 | Finding of No Significant Impact [New Animal Drugs For Use in Animal Feeds; Oxytetracycline - NADA 38-439]- FONSI | Supporting & Related Material | Freedom of Information Summary | 2008-08-07T04:00:00Z | 2008 | 8 | 2013-07-11T13:53:14Z | 0 | 0 | 09000064806b44c9 | |||
| FDA-2008-N-0039-0060 | FDA | None FDA-2008-N-0039 | Oral Dosage Form New Animal Drugs; Amprolium | Rule | Final Rule | 2008-08-06T04:00:00Z | 2008 | 8 | 2008-08-06T04:00:00Z | 2013-07-11T14:22:57Z | E8-18093 | 0 | 0 | 09000064806b15a2 | |
| FDA-2008-N-0039-0063 | FDA | None FDA-2008-N-0039 | Ceftiofur Hydrochloride (Excenel Rtu Ez) Sterile Suspension - Freedom of Information Summary | Supporting & Related Material | Freedom of Information Summary | 2008-08-06T04:00:00Z | 2008 | 8 | 2013-07-10T16:31:44Z | 0 | 0 | 09000064806b1a9b | |||
| FDA-2008-N-0039-0061 | FDA | None FDA-2008-N-0039 | Oral Dosage Form New Animal Drugs; Oxfendazole Suspension | Rule | Final Rule | 2008-08-06T04:00:00Z | 2008 | 8 | 2008-08-06T04:00:00Z | 2013-07-10T19:50:02Z | E8-18092 | 0 | 0 | 09000064806b161e | |
| FDA-2008-N-0039-0062 | FDA | None FDA-2008-N-0039 | Implantation or Injectable Dosage Form New Animal Drugs; Ceftiofur Hydrochloride | Rule | Final Rule | 2008-08-06T04:00:00Z | 2008 | 8 | 2008-08-06T04:00:00Z | 2013-07-10T16:28:17Z | E8-18094 | 0 | 0 | 09000064806b166e | |
| FDA-2008-N-0039-0059 | FDA | None FDA-2008-N-0039 | Oral Dosage Form New Animal Drugs; Sulfachlorpyridazine Powder | Rule | Final Rule | 2008-06-24T04:00:00Z | 2008 | 6 | 2008-06-24T04:00:00Z | 2013-07-11T14:16:03Z | E8-14291 | 0 | 0 | 0900006480639a99 | |
| FDA-2008-N-0039-0058 | FDA | None FDA-2008-N-0039 | New Animal Drugs; Change of Sponsors Drug Labeler Code | Rule | Final Rule | 2008-06-23T04:00:00Z | 2008 | 6 | 2008-06-23T04:00:00Z | 2013-07-11T14:33:23Z | E8-14149 | 0 | 0 | 090000648063712a | |
| FDA-2008-N-0039-0055 | FDA | None FDA-2008-N-0039 | New Animal Drugs For Use in Animal Feeds; Tylosin | Rule | Final Rule | 2008-06-17T04:00:00Z | 2008 | 6 | 2008-06-17T04:00:00Z | 2013-07-10T18:02:55Z | E8-13606 | 0 | 0 | 090000648062a67e | |
| FDA-2008-N-0039-0056 | FDA | None FDA-2008-N-0039 | Oral Dosage Form New Animal Drugs; Ivermectin Paste | Rule | Final Rule | 2008-06-17T04:00:00Z | 2008 | 6 | 2008-06-17T04:00:00Z | 2013-07-10T15:21:43Z | E8-13607 | 0 | 0 | 090000648062a642 | |
| FDA-2008-N-0039-0057 | FDA | None FDA-2008-N-0039 | Freedom of Information Summary-Supplemental Abbreviated New Animal Drug Application-ANADA 200-326-BIMECTIN Paste 1.87% (ivermectin)-Oral Paste for use in Horses | Supporting & Related Material | Freedom of Information Summary | 2008-06-17T04:00:00Z | 2008 | 6 | 2013-07-10T15:26:02Z | 0 | 0 | 090000648062a871 | |||
| FDA-2008-N-0039-0053 | FDA | None FDA-2008-N-0039 | Oral Dosage Form New Animal Drugs; Ivermectin, Fenbendazole, and Praziquantel Tablets | Rule | Final Rule | 2008-06-13T04:00:00Z | 2008 | 6 | 2013-07-10T16:34:56Z | E8-13354 | 0 | 0 | 0900006480623e54 | ||
| FDA-2008-N-0039-0054 | FDA | None FDA-2008-N-0039 | Freedom Of Information Summary NADA 141-286 Panacur Plus Chewable Dog Tablets | Supporting & Related Material | Freedom of Information Summary | 2008-06-13T04:00:00Z | 2008 | 6 | 2013-07-10T16:39:41Z | 0 | 0 | 09000064806240e3 | |||
| FDA-2008-N-0039-0052 | FDA | None FDA-2008-N-0039 | Freedom Of Information Summary - FOIS Deramaxx Chewable Tablets | Supporting & Related Material | Freedom of Information Summary | 2008-06-13T04:00:00Z | 2008 | 6 | 2013-07-10T19:10:19Z | 0 | 0 | 090000648062406b | |||
| FDA-2008-N-0039-0051 | FDA | None FDA-2008-N-0039 | Oral Dosage Form New Animal Drugs; Deracoxib | Rule | Final Rule | 2008-06-13T04:00:00Z | 2008 | 6 | 2013-07-10T19:07:16Z | E8-13353 | 0 | 0 | 0900006480623d7e | ||
| FDA-2008-N-0039-0050 | FDA | None FDA-2008-N-0039 | Freedom of Information Summary for Supplemental New Animal Drug Application - NADA 141-189, PROHEART 6 Sustained Release Injectable for Dogs (Moxidectin) Dogs over 6 months of age | Supporting & Related Material | Freedom of Information Summary | 2008-06-09T04:00:00Z | 2008 | 6 | 2013-07-10T19:18:09Z | 0 | 0 | 090000648061974d | |||
| FDA-2008-N-0039-0049 | FDA | None FDA-2008-N-0039 | Notice of Approval of Supplemental New Animal Drug Application; Moxidectin | Rule | Approval | 2008-06-09T04:00:00Z | 2008 | 6 | 2008-06-09T04:00:00Z | 2013-07-10T19:13:32Z | 08-01329 | 0 | 0 | 0900006480619532 | |
| FDA-2008-N-0039-0047 | FDA | None FDA-2008-N-0039 | Implantation or Injectable Dosage Form New Animal Drugs; Butorphanol | Rule | Final Rule | 2008-06-02T04:00:00Z | 2008 | 6 | 2008-06-02T04:00:00Z | 2013-07-10T15:16:42Z | E8-12160 | 0 | 0 | 090000648060bd12 | |
| FDA-2008-N-0039-0048 | FDA | None FDA-2008-N-0039 | Freedom of Information Summary for ANADA 200-332 - BUTORPHIC Injection (butorphanol tartrate) | Supporting & Related Material | Freedom of Information Summary | 2008-06-02T04:00:00Z | 2008 | 6 | 2013-07-10T15:19:46Z | 0 | 0 | 090000648060bf45 | |||
| FDA-2008-N-0039-0046 | FDA | None FDA-2008-N-0039 | Cefovecin - Freedom of Information Summary | Supporting & Related Material | FOIS-Freedom of Information Summary | 2008-05-22T04:00:00Z | 2008 | 5 | 2008-05-22T16:53:54Z | 0 | 0 | 09000064805f8d0f | |||
| FDA-2008-N-0039-0045 | FDA | None FDA-2008-N-0039 | Implantation or Injectable Dosage Form New Animal Drugs; Cefovecin | Rule | Final Rule | 2008-05-22T04:00:00Z | 2008 | 5 | 2008-05-22T04:00:00Z | 2013-07-09T20:04:25Z | E8-11515 | 0 | 0 | 09000064805f84e3 | |
| FDA-2008-N-0039-0044 | FDA | None FDA-2008-N-0039 | FOIS - Freedom of Information Summary | Supporting & Related Material | FOIS-Freedom of Information Summary | 2008-05-15T04:00:00Z | 2008 | 5 | 2008-05-15T12:58:59Z | 0 | 0 | 09000064805c829f | |||
| FDA-2008-N-0039-0043 | FDA | None FDA-2008-N-0039 | Implantation or Injectable Dosage Form New Animal Drugs; Flunixin | Rule | Final Rule | 2008-05-15T04:00:00Z | 2008 | 5 | 2008-05-15T04:00:00Z | 2013-07-10T15:59:09Z | E8-10856 | 0 | 0 | 09000064805c7f71 | |
| FDA-2008-N-0039-0041 | FDA | None FDA-2008-N-0039 | Certain Other Dosage Form New Animal Drugs; Sevoflurane | Rule | Final Rule | 2008-05-07T04:00:00Z | 2008 | 5 | 2013-07-09T18:52:23Z | E8-10153 | 0 | 0 | 090000648054eee0 | ||
| FDA-2008-N-0039-0042 | FDA | None FDA-2008-N-0039 | Sevoflurane; Freedom of Information Summary | Rule | Final Rule | 2008-05-07T04:00:00Z | 2008 | 5 | 2008-05-07T04:00:00Z | 2013-07-09T18:53:51Z | 0 | 0 | 090000648054f250 | ||
| FDA-2008-N-0039-0040 | FDA | None FDA-2008-N-0039 | New Animal Drugs; Change of Sponsors Name | Rule | Final Rule | 2008-04-29T04:00:00Z | 2008 | 4 | 2013-07-11T14:34:22Z | E8-09328 | 0 | 0 | 0900006480539f86 | ||
| FDA-2008-N-0039-0036 | FDA | None FDA-2008-N-0039 | New Animal Drugs; Enrofloxacin Final Rule | Rule | Final Rule | 2008-04-23T04:00:00Z | 2008 | 4 | 2013-07-10T19:23:29Z | E8-08713 | 0 | 0 | 090000648052275b | ||
| FDA-2008-N-0039-0038 | FDA | None FDA-2008-N-0039 | Freedom of Information Summary | Supporting & Related Material | FOIS-Freedom of Information Summary | 2008-04-23T04:00:00Z | 2008 | 4 | 2008-04-23T12:36:51Z | 0 | 0 | 0900006480511fc8 | |||
| FDA-2008-N-0039-0037 | FDA | None FDA-2008-N-0039 | Freedom of Information Summary | Supporting & Related Material | FOIS-Freedom of Information Summary | 2008-04-23T04:00:00Z | 2008 | 4 | 2008-04-23T12:36:50Z | 0 | 0 | 0900006480511f87 | |||
| FDA-2008-N-0039-0039 | FDA | None FDA-2008-N-0039 | Enrofloxacin Freedom of Information Summary | Supporting & Related Material | FOIS-Freedom of Information Summary | 2008-04-23T04:00:00Z | 2008 | 4 | 2008-04-23T12:36:51Z | 0 | 0 | 0900006480522960 | |||
| FDA-2008-N-0039-0035 | FDA | None FDA-2008-N-0039 | Implantation or Injectable Dosage Form New Animal Drugs; Insulin | Rule | Final Rule | 2008-04-18T04:00:00Z | 2008 | 4 | 2013-07-10T18:42:50Z | E8-08347 | 0 | 0 | 0900006480511b3a | ||
| FDA-2008-N-0039-0034 | FDA | None FDA-2008-N-0039 | Implantation or Injectable Dosage Form New Animal Drugs; Florfenicol | Rule | Final Rule | 2008-04-18T04:00:00Z | 2008 | 4 | 2013-07-10T19:52:36Z | E8-08346 | 0 | 0 | 0900006480511af1 | ||
| FDA-2008-N-0039-0033 | FDA | None FDA-2008-N-0039 | FOI Summary for NADA 141-282 ZILMAX plus RUMENSIN plus MGA (Zilpaterol Hydrochloride and Monensin USP and Melengesterol Acetate) | Supporting & Related Material | Freedom of Information Summary | 2008-04-10T04:00:00Z | 2008 | 4 | 2013-07-10T17:23:56Z | 0 | 0 | 09000064804a369b | |||
| FDA-2008-N-0039-0032 | FDA | None FDA-2008-N-0039 | New Animal Drugs For Use in Animal Feed; Zilpaterol | Rule | Final Rule | 2008-04-10T04:00:00Z | 2008 | 4 | 2013-07-10T17:18:08Z | E8-07583 | 0 | 0 | 09000064804a32eb | ||
| FDA-2008-N-0039-0031 | FDA | None FDA-2008-N-0039 | FOI Summary for ZILMAX plus RUMENSIN plus TYLAN plus MGA, NADA 141-280 (Zilpaterol Hydrochloride and Monensin USP and Tylosin Phosphate and Melengestrol Acetate) | Supporting & Related Material | Freedom of Information Summary | 2008-04-08T04:00:00Z | 2008 | 4 | 2013-07-10T17:49:51Z | 0 | 0 | 090000648046e774 | |||
| FDA-2008-N-0039-0030 | FDA | None FDA-2008-N-0039 | New Animal Drugs for Use in Animal Feed; Zilpaterol; Technical Amendment | Rule | NFR-Notice of Final Rule | 2008-04-08T04:00:00Z | 2008 | 4 | 2008-04-08T04:00:00Z | 2008-04-11T22:39:13Z | E8-07307 | 0 | 0 | 090000648046e47e | |
| FDA-2008-N-0039-0029 | FDA | None FDA-2008-N-0039 | Animal Drugs, Feeds, and Related Products; Withdrawal of Approval of NADAs; Technical Amendment | Rule | Final Rule | 2008-04-04T04:00:00Z | 2008 | 4 | 2008-04-04T04:00:00Z | 2013-07-11T14:36:14Z | E8-07103 | 0 | 0 | 0900006480439f88 | |
| FDA-2008-N-0039-0026 | FDA | None FDA-2008-N-0039 | Implantation or Injectable Dosage Form New Animal Drugs; Enrofloxacin | Rule | Final Rule | 2008-04-02T04:00:00Z | 2008 | 4 | 2013-07-10T19:26:20Z | E8-06706 | 0 | 0 | 0900006480427483 | ||
| FDA-2008-N-0039-0027 | FDA | None FDA-2008-N-0039 | FOI Summary for Zilpaterol, NADA 141-284m ZILMAX plus MGA (Zipaterol Hydrochloride and Melengestrol Acetatate) Type A Medicated Articles | Supporting & Related Material | Freedom of Information Summary | 2008-04-02T04:00:00Z | 2008 | 4 | 2013-07-10T17:16:49Z | 0 | 0 | 090000648041496e | |||
| FDA-2008-N-0039-0028 | FDA | None FDA-2008-N-0039 | NADA 141-068 Freedom of Information Summary | Supporting & Related Material | Freedom of Information Summary | 2008-04-02T04:00:00Z | 2008 | 4 | 2013-07-10T19:29:16Z | 0 | 0 | 09000064804276c7 | |||
| FDA-2008-N-0039-0025 | FDA | None FDA-2008-N-0039 | Implantation or Injectable Dosage Form New Animal Drugs; Penicillin G Benzathine and Penicillin G Procaine Suspension | Rule | Final Rule | 2008-03-31T04:00:00Z | 2008 | 3 | 2013-07-11T13:26:42Z | E8-06603 | 0 | 0 | 0900006480414884 | ||
| FDA-2008-N-0039-0024 | FDA | None FDA-2008-N-0039 | New Animal Drugs For Use in Animal Feed; Zilpaterol | Rule | NFR-Notice of Final Rule | 2008-03-31T04:00:00Z | 2008 | 3 | 2013-07-10T16:46:30Z | E8-06601 | 0 | 0 | 0900006480414833 | ||
| FDA-2008-N-0039-0023 | FDA | None FDA-2008-N-0039 | FOI Summary for Nicarbazin and Bacitracin Methylene Disalycylate NADA 141-279 | Supporting & Related Material | Freedom of Information Summary | 2008-03-26T04:00:00Z | 2008 | 3 | 2013-07-10T17:53:21Z | 0 | 0 | 0900006480409788 | |||
| FDA-2008-N-0039-0022 | FDA | None FDA-2008-N-0039 | New Animal Drugs for Use in Animal Feeds; Bacitracin Methylene Disalicylate and Nicarbazin | Rule | Final Rule | 2008-03-26T04:00:00Z | 2008 | 3 | 2013-07-10T17:51:33Z | E8-06063 | 0 | 0 | 090000648040922b | ||
| FDA-2008-N-0039-0021 | FDA | None FDA-2008-N-0039 | Implantation or Injectable Dosage Form New Animal Drugs; Oxytetracycline Solution | Rule | Final Rule | 2008-03-20T04:00:00Z | 2008 | 3 | 2013-07-10T19:19:30Z | E8-05598 | 0 | 0 | 0900006480400974 | ||
| FDA-2008-N-0039-0019 | FDA | None FDA-2008-N-0039 | New Animal Drugs for Use in Animal Feed; Zilpaterol | Rule | Final Rule | 2008-03-18T04:00:00Z | 2008 | 3 | 2013-07-10T17:55:05Z | E8-05450 | 0 | 0 | 09000064803fc2e6 | ||
| FDA-2008-N-0039-0018 | FDA | None FDA-2008-N-0039 | New Animal Drugs; Change of Sponsors Name; Iron Injection; Technical Amendment | Rule | Final Rule | 2008-03-18T04:00:00Z | 2008 | 3 | 2013-07-11T12:54:27Z | E8-05452 | 0 | 0 | 09000064803fc3f3 | ||
| FDA-2008-N-0039-0020 | FDA | None FDA-2008-N-0039 | Freedom of Information Summary-[NADA 141-278], ZILMAX plus RUMENSIN (Zilpaterol Hydrochloride and Monensin USP) | Supporting & Related Material | Freedom of Information Summary | 2008-03-18T04:00:00Z | 2008 | 3 | 2013-07-10T17:57:36Z | 0 | 0 | 09000064803fc63a | |||
| FDA-2008-N-0039-0017 | FDA | None FDA-2008-N-0039 | Implantation or Injectable Dosage Form New Animal Drugs; Penicillin G Procaine Aqueous Suspension | Rule | Final Rule | 2008-03-17T04:00:00Z | 2008 | 3 | 2008-03-17T04:00:00Z | 2013-07-11T13:42:23Z | E8-05217 | 0 | 0 | 09000064803faa5f | |
| FDA-2008-N-0039-0016 | FDA | None FDA-2008-N-0039 | Implantation or Injectable Dosage Form New Animal Drugs; Change of Sponsor; Ferric Oxide Injection; Gleptoferron Injection; Iron Dextran Complex Injection; Iron Hydrogenated Dextran Injection | Rule | Final Rule | 2008-03-10T04:00:00Z | 2008 | 3 | 2008-03-10T04:00:00Z | 2013-07-11T14:40:49Z | E8-04603 | 0 | 0 | 09000064803ef1ac | |
| FDA-2008-N-0039-0015 | FDA | None FDA-2008-N-0039 | Intramammary Dosage Forms; Cephapirin Benzathine | Rule | Final Rule | 2008-03-07T05:00:00Z | 2008 | 3 | 2008-03-07T05:00:00Z | 2013-07-11T12:48:12Z | E8-04473 | 0 | 0 | 09000064803eace5 | |
| FDA-2008-N-0039-0013 | FDA | None FDA-2008-N-0039 | New Animal Drugs; Albendazole | Rule | Final Rule | 2008-02-29T05:00:00Z | 2008 | 2 | 2013-07-11T12:43:54Z | E8-03877 | 0 | 0 | 09000064803d5031 | ||
| FDA-2008-N-0039-0014 | FDA | None FDA-2008-N-0039 | Freedom of Information Summary - [NADA-110-048-New Animal Drugs; Albendazole] | Supporting & Related Material | FOIS-Freedom of Information Summary | 2008-02-29T05:00:00Z | 2008 | 2 | 2011-06-11T16:27:26Z | 0 | 0 | 09000064803d58bf | |||
| FDA-2008-N-0039-0012 | FDA | None FDA-2008-N-0039 | Freedom of Information Summary - [ANADA-200-202-Oral Dosage Form New Animal Drugs; Ivermectin Liquid] | Supporting & Related Material | Freedom of Information Summary | 2008-02-22T05:00:00Z | 2008 | 2 | 2013-07-10T15:45:54Z | 0 | 0 | 09000064803ba587 | |||
| FDA-2008-N-0039-0011 | FDA | None FDA-2008-N-0039 | Oral Dosage Form New Animal Drugs; Altrenogest | Rule | Final Rule | 2008-02-21T05:00:00Z | 2008 | 2 | 2008-02-21T05:00:00Z | 2013-07-11T12:41:07Z | E8-03265 | 0 | 0 | 09000064803b9f24 | |
| FDA-2008-N-0039-0010 | FDA | None FDA-2008-N-0039 | Oral Dosage Form New Animal Drugs; Ivermectin Liquid | Rule | NFR-Notice of Final Rule | 2008-02-21T05:00:00Z | 2008 | 2 | 2008-02-21T05:00:00Z | 2013-07-10T15:41:57Z | E8-03266 | 0 | 0 | 09000064803b9f98 | |
| FDA-2008-N-0039-0009 | FDA | None FDA-2008-N-0039 | New Animal Drugs; Change of Sponsor; Ketamine | Rule | Final Rule | 2008-02-13T05:00:00Z | 2008 | 2 | 2008-02-13T05:00:00Z | 2013-07-10T16:07:12Z | E8-02607 | 0 | 0 | 09000064803adb81 | |
| FDA-2008-N-0039-0008 | FDA | None FDA-2008-N-0039 | Oral Dosage Form New Animal Drugs; Phenylbutazone Tablets | Rule | Final Rule | 2008-02-13T05:00:00Z | 2008 | 2 | 2008-02-13T05:00:00Z | 2013-07-11T13:04:52Z | E8-02608 | 0 | 0 | 09000064803adadb | |
| FDA-2008-N-0039-0007 | FDA | None FDA-2008-N-0039 | Oral Dosage Form New Animal Drugs: Spectinomycin | Rule | NFR-Notice of Final Rule | 2008-02-05T05:00:00Z | 2008 | 2 | 2008-04-11T22:39:13Z | E8-02065 | 0 | 0 | 09000064803a8563 | ||
| FDA-2008-N-0039-0004 | FDA | None FDA-2008-N-0039 | Freedom of Information Summary - [NADA-141-276-For Use in Animal Feed; Zilpaterol] | Supporting & Related Material | Freedom of Information Summary | 2008-02-01T05:00:00Z | 2008 | 2 | 2013-07-10T18:01:23Z | 0 | 0 | 09000064803a6603 | |||
| FDA-2008-N-0039-0006 | FDA | None FDA-2008-N-0039 | Freedom of Information Summary - [NADA-141-244-Implantation or Injectable Dosage Form New Animal Drugs; Tulathromycin] | Supporting & Related Material | Freedom of Information Summary | 2008-02-01T05:00:00Z | 2008 | 2 | 2013-07-10T18:37:53Z | 0 | 0 | 09000064803a66e8 | |||
| FDA-2008-N-0039-0005 | FDA | None FDA-2008-N-0039 | Implantation or Injectable Dosage Form New Animal Drugs; Tulathromycin | Rule | Final Rule | 2008-02-01T05:00:00Z | 2008 | 2 | 2008-02-01T05:00:00Z | 2013-07-10T18:34:59Z | E8-01906 | 0 | 0 | 09000064803a6488 | |
| FDA-2008-N-0039-0003 | FDA | None FDA-2008-N-0039 | New Animal Drugs For Use in Animal Feed; Zilpaterol | Rule | Final Rule | 2008-02-01T05:00:00Z | 2008 | 2 | 2008-02-01T05:00:00Z | 2013-07-11T14:38:03Z | E8-01903 | 0 | 0 | 09000064803a642e | |
| FDA-2008-N-0039-0002 | FDA | None FDA-2008-N-0039 | Oral Dosage Form New Animal Drugs; Clindamycin | Rule | Final Rule | 2008-01-24T05:00:00Z | 2008 | 1 | 2008-01-24T05:00:00Z | 2013-07-09T20:13:31Z | E8-01199 | 0 | 0 | 09000064803a17e1 | |
| FDA-2008-N-0039-0001 | FDA | None FDA-2008-N-0039 | Intramammary Dosage Forms; Cephapirin Sodium | Rule | Final Rule | 2008-01-17T05:00:00Z | 2008 | 1 | 2008-01-17T05:00:00Z | 2013-07-11T13:00:09Z | E8-00816 | 0 | 0 | 090000648039c6a6 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;